Role of Color Doppler Ultrasound in Lymphadenopathy
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Lymphadenopathy is defined as an abnormality in the size or character of lymph nodes caused by the invasion or propagation of either inflammatory or neoplastic cells into the nodes Accurate lymph node characterization is important for a wide number of clinical situations, including prognosis, prediction, selecting and monitoring treatment, beyond the diagnosis itself (cancer, lymphoma, or inflammatory nodes)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2018
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2018
CompletedFirst Posted
Study publicly available on registry
November 30, 2018
CompletedStudy Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedNovember 30, 2018
November 1, 2018
1 year
November 29, 2018
November 29, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
The percentage of patients with benign lymphadenopathy
comparison with the biopsy result
one year
Study Arms (1)
Study group
EXPERIMENTALpatients with lymphadenopathy
Interventions
Eligibility Criteria
You may qualify if:
- clinically enlarged lymph nodes
You may not qualify if:
- previous medical treatment or radiotherapy
- previous biopsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
November 29, 2018
First Posted
November 30, 2018
Study Start
December 1, 2018
Primary Completion
December 1, 2019
Study Completion
December 1, 2020
Last Updated
November 30, 2018
Record last verified: 2018-11